Discontinued — last reported Q3 '23
Fabrinet Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 43.2% to $275.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.4%, from $177.00K to $275.00K. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $545.00K | $1.20M | $349.00K | $325.00K | $135.00K | $192.00K | $230.00K | $73.00K | $219.00K | $229.00K | $100.00K | $88.00K | $177.00K | $130.00K | $192.00K | $275.00K |
| QoQ Change | — | +119.4% | -70.8% | -6.9% | -58.5% | +42.2% | +19.8% | -68.3% | +200.0% | +4.6% | -56.3% | -12.0% | +101.1% | -26.6% | +47.7% | +43.2% |
| YoY Change | — | — | — | — | -88.7% | -45.0% | -29.2% | -45.9% | +14.1% | -0.4% | +37.0% | -59.8% | -22.7% | +30.0% | +118.2% | +55.4% |